MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-20-0001299
Stereokem Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹13.93 Cr
▲ 29% YoY
Net profit · FY 2024
₹23.6 Lakh
Net margin 1.7%
EBITDA · FY 2024
₹2.15 Cr
EBITDA margin 15.4%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.23 Cr
Issued & subscribed
Open charges
₹1 Cr
Satisfied ₹1.4 Cr
Company age
17 yrs
Est. 2009
Directors on board
3
As per MCA filings
About Stereokem Private Limited
Data last updated:
Stereokem Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 July 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2009PTC064427. Its GSTIN is 36AADCD2571P1ZA (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.23 Cr. It was formerly known as Dis Symmetrix Private Limited. It is led by directors including Thaduri Srivani and Venkateshwar Thaduri Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.36A Ida Uppal, Hyderabad, Telangana, India – 500039.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.93 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹23.6 Lakh (net margin 1.7%) and EBITDA of ₹2.15 Cr (EBITDA margin 15.4%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 41% over five years.
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Stereokem. As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹1.4 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Stereokem Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-20-0001299). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stereokem.com.
Company details
CIN U24232TG2009PTC064427
Registration Number 064427
Incorporation Date 18 July 2009
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-20-0001299
CIN history
Stereokem has one previous CIN (Corporate Identification Number): U24232AP2009PTC064427. The current CIN is U24232TG2009PTC064427, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2009PTC064427 | Current |
| U24232AP2009PTC064427 | Previous |
Key People
Thaduri Srivani Director Venkateshwar Thaduri Kumar Director Venugopala Bandi Rao Director Recognitions & Rankings of Stereokem
Contact details
Stereokem Private Limited's registered office is in Hyderabad, Telangana. Its website is stereokem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.36A Ida Uppal, Hyderabad, Telangana, India – 500039
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stereokem Private Limited, buy the company report.
Comprehensive company report
Stereokem Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Stereokem operates one associated brand: Stereokem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops, produces, and markets pharmaceutical ingredients and provides custom synthesis services. | stereokem.com |
Business activity
The main business activity of Stereokem is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Stereokem Private Limited, buy the company report.
Financials of Stereokem Private Limited
FY 2024 filings availableStereokem Private Limited reported revenue of ₹13.93 Cr (up 29% YoY) for FY 2024.
Revenue · FY 2024
₹13.93 Cr ▲ 29%
Net profit · FY 2024
₹23.6 Lakh margin 1.7%
EBITDA · FY 2024
₹2.15 Cr margin 15.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 47%
5 years · compounded
▲ 41%
EBITDA CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 288%
5 years · compounded
▲ 56%
Revenue has grown at a compounded annual rate (CAGR) of 41% over five years, including 29% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.15 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.4% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stereokem Private Limited, buy the company report.
Board of directors of Stereokem Private Limited
Stereokem has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thaduri Srivani | Director | 16 Feb 2013 | 13 Years 8 Months | Current |
| Venkateshwar Thaduri Kumar | Director | 18 Jul 2009 | 17 Years 3 Months | Current |
| Venugopala Bandi Rao | Director | 30 Sep 2015 | 11 Years 0 Months | Current |
Peer comparison
Stereokem Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unjha Formulations Limited | ₹13.98 Cr (FY 2025) | -24.0% | Khali, Gujarat, India | |||
| Anicare Pharmaceuticals Private Limited | ₹13.97 Cr (FY 2025) | -31.0% | Mumbai, Maharashtra, India | |||
| Bentley and Remington Private Limited | ₹13.96 Cr (FY 2025) | 6.0% | Bangalore, Karnataka, India | |||
| Stereokem Private Limitedthis company | ₹13.93 Cr (FY 2024) | ₹23.6 Lakh | 1.7% | 29.0% | Hyderabad, Telangana, India | |
| Santis Pharmaceuticals Private Limited | ₹13.9 Cr (FY 2021) | 14.0% | Ahmedabad, Gujarat, India | |||
| DJ Pharmaceuticals Private Limited | ₹13.89 Cr (FY 2020) | 14.0% | Ahmedabad, Gujarat, India | |||
| Aksharam Pharma Private Limited | ₹13.87 Cr (FY 2024) | 39.0% | Wadhwancity, Gujarat, India | |||
| Aden Pharmaceuticals Private Limited | ₹13.86 Cr (FY 2025) | 6.0% | Vadodara, Gujarat, India | |||
| PLG Pharmaceuticals Private Limited | ₹13.84 Cr (FY 2024) | -20.0% | Delhi, India |
To see the full peer comparison of Stereokem Private Limited, buy the company report.
Auditor
Stereokem Private Limited is audited by B V SWAMI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B V SWAMI & CO | FY 2023 | 009151S |
Shareholding
The shareholding of Stereokem Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stereokem Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
₹1.4 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Feb 2021 | 100426853 | Hdfc Bank Limited | ₹1 Cr | Open | |
| 28 Aug 2020 | 100371721 | Others | ₹40 Lakh | Satisfied | |
| 19 Jul 2011 | 10302265 | Bank of Baroda | ₹1 Cr | Satisfied |
To see the full charge records of Stereokem Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Stereokem Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Civil suit | Filed against the company by Novartis Ag | Disposed |
To see the full case history of Stereokem Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stereokem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Stereokem has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Stereokem Pharmaceuticals Private Limited | U24100AP2012PTC112863 |
To see the full group structure of Stereokem Private Limited, buy the company report.
GST
Stereokem has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCD2571P1ZA | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stereokem Private Limited, buy the company report.
Recent activity
Stereokem Private Limited has 6 board changes on record since 2009: 3 appointments and 3 cessations. The latest: Venugopala Bandi Rao was appointed as Director on 30 Sep 2015.
AGM
Stereokem Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Stereokem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge registered on 28 Aug 2020 via Charge ID 100371721 with Others was fully satisfied on 07 Jul 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100426853 was registered on 11 Feb 2021.
Charges
A charge with Others amounted to Rs. 0.40 Cr with Charge ID 100371721 was registered on 28 Aug 2020.
Appointed
Venugopala Bandi Rao was appointed as Director.
Charges
A charge registered on 19 Jul 2011 via Charge ID 10302265 with Bank Of Baroda was fully satisfied on 01 Oct 2014.
Ceased
Sundararaman Venkataraman ceased to be Director.
Ceased
Janagani Satyanarayana ceased to be Director.
Appointed
Thaduri Srivani was appointed as Director.
Charges
A charge with Bank Of Baroda amounted to Rs. 1.00 Cr with Charge ID 10302265 was registered on 19 Jul 2011.
Ceased
Kirit Mansukhlal Doshi ceased to be Director.
2 earlier events are in the company report.
Frequently asked questions
Stereokem is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 July 2009 (17+ years old) and is registered under CIN U24232TG2009PTC064427.
Stereokem has 3 current directors:
- Thaduri Srivani - Director
- Venkateshwar Thaduri Kumar - Director
- Venugopala Bandi Rao - Director
The latest financial statements of Stereokem on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Stereokem is 36AADCD2571P1ZA, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Stereokem is U24232TG2009PTC064427. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stereokem has 1 court case on record: 1 filed against it.
Stereokem was incorporated on 18 July 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Stereokem by revenue are Unjha Formulations Limited, Anicare Pharmaceuticals Private Limited, Bentley and Remington Private Limited, Santis Pharmaceuticals Private Limited, DJ Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Venugopala Bandi Rao was appointed as Director on 30 Sep 2015. Sundararaman Venkataraman ceased to be Director on 16 Mar 2013. Janagani Satyanarayana ceased to be Director on 16 Feb 2013. Stereokem has 6 board changes on record in total.
Yes, Stereokem is registered as an MSME under Udyam registration (number: UDYAM-TS-20-0001299).
Stereokem can be reached through the website stereokem.com. Its registered office is in Hyderabad, Telangana, India.